JPRN-UMIN000010257已完成1 期
Immunotherapy using WT1 peptide and a pertussis whole cell vaccine against malignant bone and soft tissue tumors: A phase I/II study - Immunotherapy against malignant bone and soft tissue tumors
Department of Orthopaedic Surgery, Kochi Medical School0 个研究点目标入组 20 人开始时间: 2013年3月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 13years-old 至 88years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with uncontrollable infectious diseases (including active Tuberculosis). 2) Patients with severe complications(malignant hypertension, severe congestive heart failure, severe colonary insufficiency, myocardial, infarction within three months, terminal stage of liver cirrhosis, uncontrollable diabetes mellitus, severe pulmonary fibrosis, active interstitial pneumonitis, etc.). 3) Patients after allogeneic bone marrow transplantation. 4) Pregnant or breast-feeding women. 5) Patients with severe psychiatric diseases. 6) Patients who have participate in any other clinical trial. 7) Patients who have previously participated in this clinical trial. 8) Any patients disqualified by a study physician because of medical, psychological, or any other reason.
研究者
相似试验
已完成
不适用
Immunotherapy using WT1 peptide and a pertussis whole cell vaccine against Head and Neck Tumor: A phase I/II studyHead and Neck TumorJPRN-UMIN000001906Anti-tumor Immunotherapy Research Network, Department of Immunology, Kochi Medical School65
招募中
1 期
Immunotherapy using WT1 peptide and a pertussis whole cell vaccine against recurrent prostate cancer: A phase I/II studyProstate cancerJPRN-UMIN000001821Department of Immunology, Kochi University School of Medicine60
已完成
不适用
Immunotherapy using WT1 peptide against recurrent glioblastoma multiforme: A phase I/II study.glioblastoma multiformeJPRN-UMIN000002024Cancer Vaccination Therapy Research Network, Department of Immunology, Kochi Medical School30
招募中
1 期
Immunotherapy using WT1 peptide with surgical treatment, irradiation therapy, and Temozolomide administration against glioblastoma multiforme: A phase I/II study.glioblastoma multiformeJPRN-UMIN000002419Cancer Vaccination Therapy Research Network, Department of Immunology, Kochi Medical School45
招募中
1 期
W10TR-GBM2JPRN-jRCTs061180085eba Tetsuya90